Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial

PURPOSE: Treatment-emergent symptoms with adjuvant tamoxifen and aromatase inhibitors (AIs) have been associated with superior recurrence-free survival (RFS). We hypothesized that MA.27 anastrozole- or exemestane-treated patients with new or worsening vasomotor and/or joint symptoms would have impro...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Stearns, Vered, Chapman, Judith-Anne W., Ma, Cynthia X., Ellis, Matthew J., Ingle, James N., Pritchard, Kathleen I., Budd, G. Thomas, Rabaglio, Manuela, Sledge, George W., Le Maitre, Aurélie, Kundapur, Jessica, Liedke, Pedro E.R., Shepherd, Lois E., Goss, Paul E.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2015
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289722/
https://ncbi.nlm.nih.gov/pubmed/25512454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.57.6926
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker